Menopausal disorders in obese women

Cover Page


Aim. To study menopausal disorders in women suffering from obesity.

Methods. The study included 165 women in physiological postmenopausal state. Women were divided into two groups: group 1 (study group) included 87 women with obesity, group 2 (control group) consisted of 78 women without obesity. With the use of modified menopausal index (the Kupperman index) the severity of climacteric disorders was assessed. Severity of neurovegetative, metabolic-endocrine and psychoemotional symptoms was assessed according to 4-point scale (from 0 to 3 points). The number of points in each group was summarized and a modified menopausal index was obtained.

Results. It was revealed that in women with obesity severe (in 24 females, 27.5%) and moderate (in 39 patients, 44.5%) climacteric syndrome was prevalent, in patients from the control group such forms were 1.5-2 times less frequent - in 11 (14.2%) and 28 (36.2%) patients, respectively. A deeper analysis of the entire symptom complex of climacteric syndrome revealed that severe and moderate forms of neurovegetative manifestations were 2 times more common in patients with obesity, in contrast to healthy women (in 7.8% and 4.5%, 21.5% and 12.3%, respectively). Severe forms of psychoemotional manifestations were also observed 2.6 times more often in women with obesity.

Conclusion. Severity of menopausal disorders depends on obesity presence, the data obtained demonstrated that, against the background of obesity, climacteric syndrome tends to have prolonged course with predominance of severe and moderate forms.

About the authors

M A Idrisova

Dagestan State Medical University

Author for correspondence.
Makhachkala, Russia

A E Esedova

Dagestan State Medical University

Makhachkala, Russia


  1. Piya M.K., McTernan P.G., Kumar S. Adipokine in ammation and insulin resistance: the role of glucose, lipids and endotoxin. J. Endocrinol. 2013; 216 (1): T1-T15. doi: 10.1530/JOE-12-0498.
  2. Романцова Т.И. Репродукция и энергетический баланс: интегративная роль пролактина. Ожирение и метаболизм. 2014; (1): 5-18. doi: 10.14341/omet201415-18.
  3. Мычка В.Б. Женское сердце. М. 2012; 191 с.
  4. Wellons M., Ouyang P., Schreiner P.J. et al. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause. 2012; 19 (10): 1081-1087. doi: 10.1097/gme.0b013e3182517bd0.
  5. Kallen A.N., Pal L. Cardiovascular disease and ovarian function. Curr. Opin. Obstet. Gynecol. 2011; 23 (4): 258-267. doi: 10.1097/GCO.0b013e3283488a21.
  6. Gambacciani M., Rosano G., Cappagli B. et al. Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study. Climacteric. 2011; 14 (1): 18-24. doi: 10.3109/13697137.2010.520099.
  7. Григорян О.Р., Андреева Е.Н. Менопаузальный синдром у женщин с нарушениями углеводного обмена. Альтернативные и дополнительные методы терапии в климактерии (обзор литературы). Гинекология. 2011; (3): 4-7.
  8. Вихляева Е.М. Руководство по эндокринной гинекологии. М.: МИА. 2006; 784 с.
  9. Тюрин Ю.И., Макарова А.А. Анализ данных на компьютере. М.: Мысль. 2003; 280 с.



Abstract - 366

PDF (Russian) - 221




© 2017 Idrisova M.A., Esedova A.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies